Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CEDAR CoTSE:2435 -0.47%66 Debt-to-EBITDA is 3.58 as of Mar. 2026, which is 68% below its 10-year median of 11.15. GuruFocus rates TSE:2435 with a GF Score™ of 66/100 and a GF Value™ of 円238.30 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 483 Healthcare Providers & Services companies, CEDAR Co ranks worse than 86.75% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for CEDAR Co's Debt-to-EBITDA or its related term are showing as below:
TSE:2435'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 7.46 Med: 11.15 Max: 21.82
Current: 7.89
During the past 13 years, the highest Debt-to-EBITDA Ratio of CEDAR Co was 21.82. The lowest was 7.46. And the median was 11.15.
TSE:2435's Debt-to-EBITDA is ranked worse than 86.75% of 483
companies
in the Healthcare Providers & Services industry
Industry Median: 2.19
vs TSE:2435: 7.89
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
CEDAR Co Debt-to-EBITDA Related Terms
CEDAR Co Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for CEDAR Co's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2435 vs HCA, THC, DVA: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, CEDAR Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CEDAR Co Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CEDAR Co's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where CEDAR Co's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.
CEDAR Co (TSE:2435) has a Debt-to-EBITDA of 3.58 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on CEDAR Co. This is 68% below median its historical median of 11.15. Over the past decade, CEDAR Co's Debt-to-EBITDA has ranged from 7.46 to 21.82. According to the industry distribution chart, CEDAR Co ranks #419 out of 483 companies in the Healthcare Providers & Services industry, placing it in the top 86.7%.
Is CEDAR Co's Debt-to-EBITDA too high?
CEDAR Co's current Debt-to-EBITDA of 3.58 is 68% below median its 10-year median of 11.15. Over the past 10 years, this metric has ranged from a low of 7.46 to a high of 21.82. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.19. CEDAR Co's value of 3.58 is 63.5% above this industry median. Based on the distribution chart, CEDAR Co ranks #419 out of 483 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, CEDAR Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CEDAR Co's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CEDAR Co ranks #419 out of 483 companies for Debt-to-EBITDA. This places CEDAR Co in the lower half of its industry. The industry median Debt-to-EBITDA is 2.19. CEDAR Co's value of 3.58 is 63.5% above this benchmark. Historically, CEDAR Co's own Debt-to-EBITDA has ranged from 7.46 to 21.82 over the past decade. While the company's 10-year median is 11.15 vs. the industry median of 2.19, CEDAR Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.19, based on 483 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CEDAR Co's current Debt-to-EBITDA of 3.58 is 63.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on CEDAR Co. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CEDAR Co's current Debt-to-EBITDA is 3.58, which is 68% below median its own 10-year median of 11.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CEDAR Co stock overvalued right now?
Based on GuruFocus' analysis, CEDAR Co (TSE:2435) is currently considered Modestly Undervalued. The stock's GF Value™ is 円238.30, compared to a current price of 円210.00 — trading 11.9% below its estimated fair value. The current Debt-to-EBITDA is 3.58, which is 68% below median its 10-year median of 11.15 and 63.5% above the Healthcare Providers & Services industry median of 2.19. CEDAR Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For CEDAR Co (TSE:2435), the current Debt-to-EBITDA is 3.58 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CEDAR Co (TSE:2435) Overvalued in 2026?
Based on GuruFocus' analysis, CEDAR Co stock appears to be undervalued.
The current stock price of 円210.00 is trading 11.9% below its estimated GF Value™ of 円238.30.
GuruFocus considers CEDAR Co to be Modestly Undervalued.
Key valuation signals for TSE:2435:
Debt-to-EBITDA: 3.58 (68% below median its 10-year median of 11.15)
GF Value™: 円238.30 vs. price of 円210.00 (11.9% below fair value)
Industry Position: 63.5% above the Healthcare Providers & Services median (#419 of 483)
No single metric tells the full story. See the TSE:2435 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CEDAR Co Ltd is engaged in providing long-term care facilities in Japan. The services offered by the company include paid nursing homes, visiting nursing stations, helper stations, and care plan centers.
66GF Score
Get the complete analysis for TSE:2435
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2435 has been successfully added to your 
